Latest From Biotech Now

BIO Announces New Award to Honor Women in the Field Of Industrial Biotechnology

Pac_Rim115x75

BIO recently announced the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. This award will be presented to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. The winner will be awarded this honor at the 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy, to be held December 7-9, 2014 in San Diego, California. The award is Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , ,

What to Watch: Vaccines – Calling the Shots

vaccines-calling-shots-vi

Recently, PBS’s NOVA had an episode on the reemergence of diseases (including measles, whooping cough, and mumps) that had previously been largely eradicated in the US by vaccines, in part because nervous parents are skipping their children’s shots. At least ten percent of parents delay or skip some recommended vaccines, and one percent don’t vaccinate at all. What’s driving people away, and what are the consequences? Those are the questions explored in Vaccines — Calling Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Herbicides and 2, 4-D: Cutting Through the Controversy

admin-ajax (2)

A number of media outlets reported on last week’s decision by the USDA to approve the use of genetically modified corn and soybean seeds that are resistant to the herbicide known as 2, 4-D. Farmers and growers, anxious for new tools in the ever-evolving fight against weeds, have been long awaiting the approval. The American Soybean Association, for example, issued a statement cheering the move and calling on the Environmental Protection Agency (EPA) to now Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Investment in NJ Biotech is Way Up

graph

Total funding of New Jersey life sciences companies spiked in 2013 with approximately $900 million in both early and late-stage investments, according to a new report from BioNJ. This figure represents well over 200 percent growth over the prior year. Funding was helped by seven New Jersey companies that completed initial public offerings (IPOs) in 2013. Furthermore, industry wages averaged $126,794 in 2012, led by pharmaceuticals ($137,949), followed by biotechnology ($132,576) and medical devices ($94,652). Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

GMO Answers Provides an Overview of GMOs in Medicine

GMO Answers

With genetically engineered therapies for the infectious disease, Ebola, currently undergoing testing for safety and efficacy, GMO Answers is highlighting the use of genetic engineering in other biomedical applications. The post’s author, Richard Green, also looks at why GMOs, though used in both agriculture and medicine, are more controversial in agricultural applications. The technology of genetic modification or genetic engineering was first developed in the early 1970s, commercialized in pharmaceutical applications in the early 1980s, and then agricultural Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,